Exploiting Iron Metabolism as a Therapeutic Vulnerability in Glioblastoma

被引:3
|
作者
Nabavizadeh, Ali [1 ,3 ]
Bagley, Stephen J. [2 ]
机构
[1] Univ Penn, Hosp Univ Penn, Perelman Sch Med, Dept Radiol, Philadelphia, PA USA
[2] Univ Penn, Abramson Canc Ctr, Philadelphia, PA USA
[3] Hosp Univ Penn, Dept Radiol, Silverstein Bldg 3400 Spruce St, Philadelphia, PA 19104 USA
关键词
D O I
10.1158/1078-0432.CCR-23-3027
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In this CCR Translations, we discuss pharmacologic ascorbate as a novel therapeutic for glioblastoma (GBM). Aberrant iron metabolism in GBM can be assessed noninvasively by MRI and exploited to potentially improve the efficacy of chemoradiotherapy. We contextualize the study's results and discuss the next steps to further develop this paradigm.
引用
收藏
页码:255 / 256
页数:2
相关论文
共 50 条
  • [41] Pharmacological targeting of one-carbon metabolism as a novel therapeutic strategy for glioblastoma
    Sun, Yanfei
    Mu, Guangjing
    Xue, Zhiwei
    Li, Xingang
    Lin, Xiaoying
    Han, Mingzhi
    JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
  • [42] Glioblastoma Sensitization to Therapeutic Effects by Glutamine Deprivation Depends on Cellular Phenotype and Metabolism
    Alina A. Isakova
    Irina N. Druzhkova
    Artem M. Mozherov
    Diana V. Mazur
    Nadezhda V. Antipova
    Kirill S. Krasnov
    Roman S. Fadeev
    Marine E. Gasparian
    Anne V. Yagolovich
    Biochemistry (Moscow), 2024, 89 (10) : 1744 - 1758
  • [43] Exploiting Microglial Functions for the Treatment of Glioblastoma
    Dello Russo, Cinzia
    Lisi, Lucia
    Tentori, Lucio
    Navarra, Pierluigi
    Graziani, Grazia
    Combs, Colin K.
    CURRENT CANCER DRUG TARGETS, 2017, 17 (03) : 267 - 281
  • [44] Exploiting AML vulnerability: glutamine dependency
    Emadi, Ashkan
    BLOOD, 2015, 126 (11) : 1269 - 1270
  • [45] Exploiting oncogene-conferred glutamine addiction as a therapeutic vulnerability in resistant mantle cell lymphoma.
    Li, Lingzhi
    Jiang, Changying
    Navsaria, Lucy J.
    Liu, Yang
    McIntosh, Joseph M.
    Wang, Michael
    Yao, Yinxin
    CANCER RESEARCH, 2021, 81 (13)
  • [46] Iron Metabolism in Cardiovascular Disease: Physiology, Mechanisms, and Therapeutic Targets
    Sawicki, Konrad Teodor
    De Jesus, Adam
    Ardehali, Hossein
    CIRCULATION RESEARCH, 2023, 132 (03) : 379 - 396
  • [47] Iron metabolism: backfire of cancer cell stemness and therapeutic modalities
    Yu, Rong
    Hang, Yinhui
    Tsai, Hsiang-i
    Wang, Dongqing
    Zhu, Haitao
    CANCER CELL INTERNATIONAL, 2024, 24 (01)
  • [48] Therapeutic Benefit of Regulating Iron Metabolism in Spontaneous Lupus Nephritis
    Scindia, Yogesh
    Wlazlo, Ewa
    Ghias, Elizabeth
    Voi, Valentina
    Cechova, Sylvia
    Leeds, Joseph
    Swaminathan, Sundararaman
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
  • [49] COPPER AND MANGANESE METABOLISM DURING ADMINISTRATION OF THERAPEUTIC DOSES OF IRON
    NASOLODIN, VV
    RUSIN, VY
    VOROBYOV, VA
    TERAPEVTICHESKII ARKHIV, 1984, 56 (09): : 116 - 119
  • [50] Novel therapeutic targets in epilepsy: oxidative stress and iron metabolism
    Li, Y. -F.
    Thom, M.
    Jacques, T. S.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2020, 46 (06) : 519 - 521